The reactive dicarbonyl metabolite, methylglyoxal (MG), is increased in obesity and diabetes and is implicated in the development of insulin resistance, type 2 diabetes mellitus and vascular complications of diabetes. Dicarbonyl stress is the metabolic state of abnormal high MG concentration. MG is an arginine-directed glycating agent and precursor of the major advanced glycation endproduct, arginine-derived hydroimidazolone MG-H1. MG-H1 is often formed on protein surfaces and an uncharged hydrophobic residue, inducing protein structural distortion and misfolding. Recent studies indicate that dicarbonyl stress in human endothelial cells and fibroblasts in vitro induced a proteomic response consistent with activation of the unfolded protein ...
Glyoxalase-1 (GLO1) is a ubiquitously expressed cytosolic protein which plays a role in the natural ...
Diabetes was the first disease state where evidence emerged for increased formation of methylglyoxal...
Chronic hyperglycemia and oxidative stress in Type 2 Diabetes Mellitus trigger cellular dysfunction ...
Dicarbonyl stress is the abnormal accumulation of dicarbonyl metabolites leading to increased protei...
Metabolic dysfunction of endothelial cells in hyperglycemia contributes to the development of vascul...
The reactive dicarbonyl metabolite methylglyoxal (MG) is the precursor of the major quantitative adv...
The study of the glyoxalase system by Thornalley and co-workers in clinical diabetes mellitus and co...
Dicarbonyl stress occurs when dicarbonyl metabolites (i.e., methylglyoxal, glyoxal and 3-deoxyglucos...
Methylglyoxal (MG) is a potent protein glycating agent. Glycation is directed to guanidino groups of...
The formation and accumulation of methylglyoxal (MGO), a highly reactive dicarbonyl compound, has be...
Open Access articleThe glyoxalase system in the cytoplasm of cells provides the primary defence agai...
Late vascular complications play a prominent role in the diabetes-induced increase in morbidity and ...
Dicarbonyl stress is the abnormal accumulation of dicarbonyl metabolites leading to increased protei...
Advanced glycated end-products (AGEs) are a heterogenous group of compounds formed through the Maill...
Molecular pathological pathways leading to multi-organ failure in critical illness are progressively...
Glyoxalase-1 (GLO1) is a ubiquitously expressed cytosolic protein which plays a role in the natural ...
Diabetes was the first disease state where evidence emerged for increased formation of methylglyoxal...
Chronic hyperglycemia and oxidative stress in Type 2 Diabetes Mellitus trigger cellular dysfunction ...
Dicarbonyl stress is the abnormal accumulation of dicarbonyl metabolites leading to increased protei...
Metabolic dysfunction of endothelial cells in hyperglycemia contributes to the development of vascul...
The reactive dicarbonyl metabolite methylglyoxal (MG) is the precursor of the major quantitative adv...
The study of the glyoxalase system by Thornalley and co-workers in clinical diabetes mellitus and co...
Dicarbonyl stress occurs when dicarbonyl metabolites (i.e., methylglyoxal, glyoxal and 3-deoxyglucos...
Methylglyoxal (MG) is a potent protein glycating agent. Glycation is directed to guanidino groups of...
The formation and accumulation of methylglyoxal (MGO), a highly reactive dicarbonyl compound, has be...
Open Access articleThe glyoxalase system in the cytoplasm of cells provides the primary defence agai...
Late vascular complications play a prominent role in the diabetes-induced increase in morbidity and ...
Dicarbonyl stress is the abnormal accumulation of dicarbonyl metabolites leading to increased protei...
Advanced glycated end-products (AGEs) are a heterogenous group of compounds formed through the Maill...
Molecular pathological pathways leading to multi-organ failure in critical illness are progressively...
Glyoxalase-1 (GLO1) is a ubiquitously expressed cytosolic protein which plays a role in the natural ...
Diabetes was the first disease state where evidence emerged for increased formation of methylglyoxal...
Chronic hyperglycemia and oxidative stress in Type 2 Diabetes Mellitus trigger cellular dysfunction ...